TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $247,000 | -42.8% | 18,141 | -31.3% | 0.01% | -40.0% |
| Q3 2021 | $432,000 | -14.5% | 26,403 | -11.9% | 0.01% | -9.1% |
| Q2 2021 | $505,000 | -27.1% | 29,982 | -21.0% | 0.01% | -31.2% |
| Q1 2021 | $693,000 | -74.6% | 37,959 | -74.7% | 0.02% | -71.4% |
| Q4 2020 | $2,727,000 | +2.9% | 149,861 | +0.8% | 0.06% | -5.1% |
| Q3 2020 | $2,651,000 | -23.6% | 148,607 | -23.2% | 0.06% | -26.2% |
| Q2 2020 | $3,471,000 | -2.2% | 193,613 | -17.2% | 0.08% | -12.1% |
| Q1 2020 | $3,550,000 | +41.2% | 233,840 | +83.5% | 0.09% | +78.4% |
| Q4 2019 | $2,514,000 | +112.5% | 127,429 | +119.4% | 0.05% | +88.9% |
| Q1 2019 | $1,183,000 | – | 58,089 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |